GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Rating:
Accumulate
REGN
up 3,453.50 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Accumulate with price target $21 by ThinkEquity

Posted on: Tuesday,  May 5, 2009  8:25 AM ET by ThinkEquity

ThinkEquity rated Accumulate Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 05/05/2009, when the stock price was $15.14. Since
then, Regeneron Pharmaceuticals, Inc. has gained 3453.50% as of 01/27/2016's recent price of $538.00.
If you would have followed this ThinkEquity's recommendation on REGN, you would have gained 3453.5% of your investment in 2458 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/5/2009 8:25 AM Buy
None
15.14 21.00
as of 12/31/2009
1 Week up  43.44 %
1 Month up  81.36 %
3 Months up  72.43 %
1 YTD up  119.81 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy